Showing results (21-30 of 2,634) with videos related to

Sort By:
Pageof 264
Archives of Orthopaedic and Trauma Surgery|January 1, 1990
Quantitative and functional restorations and alterations of peripheral lymphocytes in patients with autologous spleen implantationL Bergmann, W Böttcher, R M Seufert, et al.
Scandinavian Journal of Haematology|February 1, 1985
T-cell subsets in malignant lymphomas and monoclonal gammopathiesL Bergmann, P S Mitrou, W Kelker, et al.
Leukemia Research|July 1, 1995
AML blasts variably express interleukin 2 receptor alpha, beta or gamma chains without measurable effects on proliferation, cytokine message expression or surface expression of adhesion molecules upon stimulation with interleukin 2E Weidmann, J Brieger, L Bergmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1993
Immunosuppressive effects and clinical response of fludarabine in refractory chronic lymphocytic leukemiaL Bergmann, K Fenchel, B Jahn, et al.
Cancer Immunology, Immunotherapy : CII|May 1, 1994
In vivo regulation of transforming growth factor beta 1 transcription by immunotherapy: interleukin-2 impairs interferon-alpha-stimulated increase in steady-state mRNA levels of transforming growth factor beta 1B Jahn, J Brieger, K Fenchel, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|August 1, 1992
Rapid cytokine release in cancer patients treated with interleukin-2E Weidmann, L Bergmann, J Stock, et al.
Natural Immunity and Cell Growth Regulation|January 1, 1990
Influence of various cytokines on the induction of lymphokine-activated killer cellsL Bergmann, E Weidmann, B Bungert, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1984
High-dose adriamycin (ADM) and cis-platinum (DDP) in advanced soft-tissue sarcomas and invasive thymomas. A pilot studyT H Klippstein, P S Mitrou, K J Kochendörfer, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 1995
Recombinant human granulocyte-macrophage colony-stimulating factor after combined chemotherapy in high-grade non-Hodgkin's lymphoma--a randomised pilot studyL Bergmann, T Karakas, A Knuth, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1995
The Wilms' tumor gene is frequently expressed in acute myeloblastic leukemias and may provide a marker for residual blast cells detectable by PCRJ Brieger, E Weidmann, U Maurer, et al.
Pageof 264